ArticlePharmaceutics2026

A Mechanistic Pharmacokinetic/Pharmacodynamic Model for Sequence-Dependent Synergy in Pemetrexed-Osimertinib Combinations Against Non-Small Cell Lung Cancer (NSCLC): Translational Insights.

Kuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.